Auxly Cannabis Valuation
| 3KF Stock | EUR 0.01 0.01 47.00% |
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Auxly Cannabis Group prevailing Real Value cannot be determined due to lack of data. The current price of Auxly Cannabis Group is €0.0106. Our model approximates the value of Auxly Cannabis Group from analyzing the firm fundamentals such as Current Valuation of 321.75 M, price to earning of 20.65 X, and Return On Equity of -35.01 as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Auxly Cannabis' price fluctuation is out of control at this time. Calculation of the real value of Auxly Cannabis Group is based on 3 months time horizon. Increasing Auxly Cannabis' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Auxly stock is determined by what a typical buyer is willing to pay for full or partial control of Auxly Cannabis Group. Since Auxly Cannabis is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Auxly Stock. However, Auxly Cannabis' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0106 | Real 0.0 | Hype 0.0 | Naive 0.0124 |
The real value of Auxly Stock, also known as its intrinsic value, is the underlying worth of Auxly Cannabis Group Company, which is reflected in its stock price. It is based on Auxly Cannabis' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Auxly Cannabis' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Auxly Cannabis Group helps investors to forecast how Auxly stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Auxly Cannabis more accurately as focusing exclusively on Auxly Cannabis' fundamentals will not take into account other important factors: Auxly Cannabis Total Value Analysis
Auxly Cannabis Group is presently estimated to have takeover price of 321.75 M with market capitalization of 347.95 M, debt of 68.94 M, and cash on hands of 156.23 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Auxly Cannabis fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
321.75 M | 347.95 M | 68.94 M | 156.23 M |
Auxly Cannabis Investor Information
The company has Price-to-Book (P/B) ratio of 1.15. In the past many companies with similar price-to-book ratios have beat the market. Auxly Cannabis Group recorded a loss per share of 0.08. The entity had not issued any dividends in recent years. Based on the key indicators related to Auxly Cannabis' liquidity, profitability, solvency, and operating efficiency, Auxly Cannabis Group is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Auxly Cannabis Asset Utilization
One of the ways to look at asset utilization of Auxly is to check how much profit was generated for every dollar of assets it reports. Auxly Cannabis Group shows a negative utilization of assets of -9.93 percent, losing €0.0993 for each euro of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each euro of assets it shows. Put another way, asset utilization of Auxly Cannabis Group shows how discouraging it operates for each euro spent on its assets.Auxly Cannabis Profitability Analysis
The company reported the revenue of 1.51 M. Net Loss for the year was (20.6 M) with profit before overhead, payroll, taxes, and interest of 6.47 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Auxly Cannabis' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Auxly Cannabis and how it compares across the competition.
About Auxly Cannabis Valuation
The stock valuation mechanism determines Auxly Cannabis' current worth on a weekly basis. Our valuation model uses a comparative analysis of Auxly Cannabis. We calculate exposure to Auxly Cannabis's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Auxly Cannabis's related companies.Auxly Cannabis Group Inc. operates as an integrated cannabis company. Auxly Cannabis Group Inc. was incorporated in 1987 and is based in Vancouver, Canada. Cannabis Wheaton operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange.
8 Steps to conduct Auxly Cannabis' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Auxly Cannabis' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Auxly Cannabis' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Auxly Cannabis' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Auxly Cannabis' revenue streams: Identify Auxly Cannabis' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Auxly Cannabis' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Auxly Cannabis' growth potential: Evaluate Auxly Cannabis' management, business model, and growth potential.
- Determine Auxly Cannabis' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Auxly Cannabis' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Auxly Stock analysis
When running Auxly Cannabis' price analysis, check to measure Auxly Cannabis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Auxly Cannabis is operating at the current time. Most of Auxly Cannabis' value examination focuses on studying past and present price action to predict the probability of Auxly Cannabis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Auxly Cannabis' price. Additionally, you may evaluate how the addition of Auxly Cannabis to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |